RSSCancer

EU invests €35 million to develop #ArtificialIntelligence solutions for #Cancer prevention and treatment

EU invests €35 million to develop #ArtificialIntelligence solutions for #Cancer prevention and treatment

| July 10, 2019

The European Commission has launched a call for proposals with €35 million available aimed to support  the development of analysis of health images for cancer diagnostics based on Artificial Intelligence, as well as other tools and analytics focused on the prevention, prediction and treatment of the most common forms of cancer.  The call is part of the Horizon […]

Continue Reading

Commission launches work on major research and innovation missions for #Cancer, #Climate, #Oceans and #Soil

Commission launches work on major research and innovation missions for #Cancer, #Climate, #Oceans and #Soil

| July 8, 2019

The European Commission has launched the work on five major research and innovation missions that will be part of Horizon Europe, which is the next framework programme (2021-2027) and has a proposed budget of €100 billion. The European research and innovation missions aim to deliver solutions to some of the greatest challenges facing our world, including […]

Continue Reading

Workplace risks: Final vote on protection from #Carcinogens, including diesel fumes

Workplace risks: Final vote on protection from #Carcinogens, including diesel fumes

| December 14, 2018

MEPs updated rules to protect workers from exposure to carcinogenic and mutagenic substances, including diesel fumes, in a vote this week. In order to protect some 3.6 million workers in the EU potentially exposed to diesel engine exhaust emissions (DEEE), the Parliament succeeded in including diesel fumes in the scope of the new rules and […]

Continue Reading

#Cancer – Protecting people from #Carcinogens at work

#Cancer – Protecting people from #Carcinogens at work

| December 10, 2018

Cancer is linked to more than half of work-related deaths in the EU. Learn about the EU rules to protect people from carcinogens in the workplace. In 2017, MEPs set exposure limits on 11 additional carcinogens during the first revision of the 2004 directive to limit harmful substances in the workplace. Today (10 December) MEPs […]

Continue Reading

#EAPM – Climate change is one thing, Mr President – changes in cancer treatments are another…

#EAPM – Climate change is one thing, Mr President – changes in cancer treatments are another…

| October 15, 2018

Love them or loath them, politicians from left, right and centre are an essential part of the landscape in every important arena affecting citizens, writes European Alliance for Personalised Medicine (EAPM) Executive Director Denis Horgan. Whatever one may make of the recent news that US President Donald Trump no longer believes that climate change is a […]

Continue Reading

#IEA sets its sights on Brussels

#IEA sets its sights on Brussels

| August 1, 2018

Not content with its regular contact with British ministers, the Insititute of Economic Affairs (IEA) has set its sights on influencing European actors with its uncompromising free trade and deregulation message. The main issue at stake here is transparency, writes Catherine Feore. The Guardian and Greenpeace journalists (Unearthed) covertly videoed the Chief Executive of the […]

Continue Reading

Juncker Plan supports €40 million loan to finance research of #CancerTreatment

Juncker Plan supports €40 million loan to finance research of #CancerTreatment

| July 30, 2018

The Juncker Plan’s European Fund for Strategic Investments (EFSI) has provided its backing to a European Investment Bank (EIB) loan worth €40 million to biotechnology company Nanobiotix. The loan will help finance research and development by Nanobiotix of innovative cancer treatments. Commenting on the agreement, Commissioner Vytenis Andriukaitis said: “Cancer is the second-highest cause of death in the EU […]

Continue Reading